HealthTell, Inc.

HealthTell’s mission is to provide the most accurate and affordable diagnostic for early disease detection—all from a simple drop of blood.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location San Ramon, CA, US
  • Currency USD
  • Founded 2012
  • Employees 32
  • Website healthtell.com

Company Summary

HealthTell sells an Early Stage Cancer Diagnostic Blood Test to physicians in order to solve one of the most costly burdens to society and healthcare (cancer is the 2nd leading cause of death and expenditure in healthcare). Unlike biomarkers (PSA) and imaging (CT Scans), our solution is simple, accurate, and affordable. The test is performed on microfabricated peptide arrays, designed to query multiple antibodies present in the bloodstream.

Team

  • Bill Colston
    CEO

    Bill Colston, CEO is an experienced and successful entrepreneur. After a 25 year career at Lawrence Livermore Labs in progressive leadership positions, he departed to start Quantalife. IP was licensed from the lab and he built a team that within three years progressed from concept to product, marketed the innovative technology, and sold it to BioRad for over $200M.

  • Cynthia Hibbard
    Director Marketing

    Cynthia has broad experience marketing both consumer, diagnostic and healthcare products for Fortune 100 firms. A graduate of Krannert School of Management at Purdue, she has led national and international brand development for P&G, Schering Plough (Merck) J&J (Diabetes Monitoring), and SC Johnson. Additionally, she started and directed her own company in a niche market leveraging unique skills.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free